ALSUntangled No. 37: Inosine.
Publication
, Journal Article
ALSUntangled Group,
Published in: Amyotroph Lateral Scler Frontotemporal Degener
May 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Amyotroph Lateral Scler Frontotemporal Degener
DOI
EISSN
2167-9223
Publication Date
May 2017
Volume
18
Issue
3-4
Start / End Page
309 / 312
Location
England
Related Subject Headings
- Treatment Outcome
- Risk
- Inosine
- Humans
- Clinical Trials as Topic
- Amyotrophic Lateral Sclerosis
- 3209 Neurosciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
ALSUntangled Group, . (2017). ALSUntangled No. 37: Inosine. Amyotroph Lateral Scler Frontotemporal Degener, 18(3–4), 309–312. https://doi.org/10.1080/21678421.2016.1223270
ALSUntangled Group, Salvador. “ALSUntangled No. 37: Inosine.” Amyotroph Lateral Scler Frontotemporal Degener 18, no. 3–4 (May 2017): 309–12. https://doi.org/10.1080/21678421.2016.1223270.
ALSUntangled Group. ALSUntangled No. 37: Inosine. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3–4):309–12.
ALSUntangled Group, Salvador. “ALSUntangled No. 37: Inosine.” Amyotroph Lateral Scler Frontotemporal Degener, vol. 18, no. 3–4, May 2017, pp. 309–12. Pubmed, doi:10.1080/21678421.2016.1223270.
ALSUntangled Group. ALSUntangled No. 37: Inosine. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3–4):309–312.
Published In
Amyotroph Lateral Scler Frontotemporal Degener
DOI
EISSN
2167-9223
Publication Date
May 2017
Volume
18
Issue
3-4
Start / End Page
309 / 312
Location
England
Related Subject Headings
- Treatment Outcome
- Risk
- Inosine
- Humans
- Clinical Trials as Topic
- Amyotrophic Lateral Sclerosis
- 3209 Neurosciences
- 1109 Neurosciences
- 1103 Clinical Sciences